Thomson Reuter’s 2012 Western M&A Forum
Public/public deal process and terms are driven and constrained by the Revlon market check mandate, the target’s insistence on deal certainty (and possibly reverse termination fees), the increased risk of regulatory intervention, the near certainty of a M&A strike suit and the possibility of derivative litigation. In addition, public companies continue to look to spin-offs and divestitures to stay focused on core competencies and patent monetization efforts. Deal volume has been driven by large pharma/healthcare deals and cross-border deals.
Topics to be covered include: